drugset / Trial / NCT00641797

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

NCT00641797

Completed 26 enrolled Lehigh Valley Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods of treatment. Patients will be randomized to receive the more common conventional medication therapy versus the canalith repositioning technique. All patients enrolled into this study are emergency department patients who have been diagnosed with BPPV via a positive Dix-Hallpike Maneuver. The hypothesis of this study is that vestibular rehabilitation will allow for resolution of symptoms without the use of conventional medication therapy in the acute management of BPPV in the emergency department patient.

Timeline

Start
2006-11
Primary completion
2010-12
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diphenhydramine Unknown 25 mg Oral
Comparator Diphenhydramine Unknown 50 mg Oral
Comparator Lorazepam Small molecule 1 mg Oral
Comparator Lorazepam Small molecule 5 mg Oral
Comparator Meclizine Small molecule 25 mg Oral
Comparator Ondansetron Other / unclassified 4 mg Oral
Comparator Ondansetron Other / unclassified 8 mg Oral